Daniel J. Herold, MD

home / authors / daniel-j-herold-md

Articles

A 64-Year-Old Man With Germline BRCA2-Mutated Breast Cancer: Known and Unknown Aspects of Male Breast Cancer

Mehmet Sitki Copur, MD, FACP;Jacqueline R. Kelly, MD, MSc;Nicholas Lintel, MD;Bronson Riley, MS;Daniel J. Herold, MD;Shellie Faris, MD;Whitney Wedel, MD;Adam J. Horn, MD

August 13th 2021

This study presents a male breast cancer case with a germline BRCA2 mutation and discusses the epidemiologic, pathologic, and clinical characteristics along with treatment and follow-up recommendations in view of our recent understanding of the disease.

Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemotherapy: Review of Histologic and Clinical Spectrum of Epithelial Neoplastic Mucinous Lesions of the Appendix

Mehmet Sitki Copur, MD;Allison M. Cushman-Vokoun, MD, PhD;James Padussis, MD;Whitney Wedel, MD;Caleb W. Schroeder, MD;Daniel J. Herold, MD;Nicholas Lintel, MD;Adam J. Horn, MD

June 23rd 2021

Mehmet Sitki Copur, MD, and colleagues examine the case of a 65-year-old patient with appendiceal mucinous neoplasms of the appendix who was treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.